Released Apr 30, 2018, after the close
10-Q filed Apr 30, 2018, 30 days after period end · 0001564590-18-009864
Q1 2018 · 10-Q
Revenue$108.71M$108.71M +5.8% vs Q1 2017−7.0% vs Q4 2017
Net Income$5.23M$5.23M N/M vs Q1 2017+233.3% vs Q4 2017
EPS Diluted$0.27$0.27 N/M vs Q1 2017+237.5% vs Q4 2017
Gross Profit$84,562,000+5.5%
Operating Income$7,870,000+33.0%
Operating Cash Flow-$3,560,000N/M
Free Cash Flowderived-$6,391,000N/M
Margins · derived
Gross margin77.8%−0.2 pt vs Q1 2017
Operating margin7.2%+1.5 pt vs Q1 2017
Net margin4.8%+7.4 pt vs Q1 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $108.71M | $102.74M | $98.68M | $89.76M |
| Net Income | $5.23M | -$2.65M | $3.84M | -$8.38M |
| EPS Diluted | $0.27 | -$0.15 | $0.20 | -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR